Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: scaram(o)uche who wrote (427)	5/17/1998 5:12:00 AM
From: Asymmetric	Read Replies (1) \| Respond to of 2001

Gliatech Inc. Files To Offer 2 Million Common Shares Dow Jones Newswires -- May 15, 1998 WASHINGTON -- Gliatech Inc. (GLIA) filed to offer 2 million common shares. In a filing Friday with the Securities and Exchange Commission, the company said proceeds from the offering will be used for the U.S development of ADCON-P and ADCON-T/N, introduction of ADCON-L into the U.S. Market, research and development, working capital and general purposes. Cowen & Co., Furman Selz and Vector Securities International Inc. will underwrite the offering, which has an overallotment option of up to an additional 300,000 shares. Based in Cleveland, Ohio, the company develops and markets medicinal products designed to inhibit surgical scarring and adhesion. (Any thoughts regarding timing of offering? Personally would have thought they would have waited until AFTER FDA approval. Peter.)